NCT02031822View on ClinicalTrials.gov

Two US-guided Techniques for Greater Occipital Nerve Blocks

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

September 30, 2017

Study Completion Date

May 31, 2018

Conditions
Primary Headache
Interventions
PROCEDURE

US-guided Greater Occipital Nerve Injection

Medication injected around the greater occipital nerve: 2ml 0.5% bupivacaine with epinephrine 1:200,000 and Depo-Medrol 40mg.

Trial Locations (2)

M5G 1X5

Mount Sinai Hospital, Toronto

M5T 2S8

Toronto Western Hospital, University Health Network, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER

NCT02031822 - Two US-guided Techniques for Greater Occipital Nerve Blocks | Biotech Hunter | Biotech Hunter